Inspire Medical Systems is working through short-term rollout delays for its newer sleep apnea implant system, and the story hinges on whether those hiccups clear as clinics ramp back up. If training, billing, and reimbursement changes fall into place, the company could see procedure demand snap back—but rising competition, higher spending, and shifts in how sleep apnea gets treated could still derail the recovery.Read more
A sleep apnea device maker could get a fresh boost as doctors adopt its newer implant and more patients are guided through care using remote tools. But the story depends heavily on one main product, and growing interest in non-surgical treatments and shifting insurance rules could slow momentum.Read more
Inspire Medical Systems sells an implanted device for sleep apnea, but growing pressure from insurers and a shift toward at-home alternatives could slow its growth and squeeze profits. The story hinges on whether delayed rollouts and rising costs are temporary bumps—or signs that demand is starting to peak in its core market.Read more
No trending discussion available.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
